Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

PE Holdings May Be Sitting on Preferred Stock Powder Kegs

Related Content

CFPB Withdraws Proposed Rule on Data Broker Practices

Federal Reserve Rescinds Bank Guidance, and the Federal Reserve, FDIC and OCC Withdraw 2023 Joint Statements, Regarding Crypto-Asset and Dollar Token Activities

Washington Becomes First State to Adopt Filing Requirements for HSR-Reportable Transactions Outside of Healthcare

CFPB Announces Potential Relief From Registration Requirements for Small Loan Providers

Delaware Creates More Corporate Clarity and Overhauls Rules Governing Conflicted Transactions

Federal Bank Regulatory Agencies Intend to Rescind 2023 CRA Final Rule

M&A Deal Timelines Rise Across the Globe

What Are “Books and Records”? Delaware Reduces Uncertainty Surrounding Stockholder Inspection Rights

PLI 40th Midyear SEC Reporting & FASB Forum - New York

Goodwin Named to Los Angeles Business Journal’s 2025 List of Largest Law Firms in LA

Vigil Neuroscience To Be Acquired by Sanofi For 470 Million and Contingent Value Rights

23andMe Enters into Asset Purchase Agreement to be Acquired by Regeneron for $256 Million

Goodwin Scales Life Sciences Practice in Boston with the Arrival of Partner Felipe Heiderich

Goodwin Represents SevenRooms in Agreement to be Acquired by DoorDash to Enhance Commerce Platform Offerings

Kronos Bio To Be Taken Private by Concentra Biosciences

Goodwin’s Israel Practice Highly Ranked by Chambers and Israel Desks

Technology

Private Equity

Mergers & Acquisitions

Capital Markets